Nirsevimab [1989556-22-0]

TargetMol Chemicals

Nirsevimab

9

Antibody

Research Use Only

Nirsevimab

SDS-PAGE:98.2%;SEC-HPLC:98.1%

Nirsevimab (MEDI8897) is a recombinant human respiratory syncytial virus (RSV) monoclonal antibody with a modified Fc region, efficiently targeting RSV-B with a Kd value of 1.5 nM, and can be used to prevent RSV infection.

3 years

-20°C

12352203